Eight new homes for first-time buyers

Here’s a round-up of some of the best houses available via schemes that offer some form of help for first-time buyers

Nanobiotix S.A. (NNBXF)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

9.10

0.00

(0.00%)

At close: 03:47PM EDT

Loading interactive chart…

Business Wire
CORRECTING and REPLACING: NANOBIOTIX Provides First Quarter Operational and Financial Update
PARIS & CAMBRIDGE, Mass., May 19, 2022--Regulatory News: This replaces the announcement made at 4:40PM EDT/20:40 CEST on May 18 due to the following correction: Updated date in "First Quarter Operational Highlights" section.
Business Wire
NANOBIOTIX Provides First Quarter Operational and Financial Update
PARIS & CAMBRIDGE, Mass., May 18, 2022--Regulatory News: NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the "Company"), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced operational progress, cash position (unaudited) for the first quarter of 2022, and extension of operating runway into Q4 2023.
Business Wire
NANOBIOTIX to Present During the Jefferies Healthcare Conference in June 2022
PARIS & CAMBRIDGE, Mass., May 17, 2022--Regulatory News: NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that Laurent Levy, co-founder and chairman of the executive board, and Bart Van Rhijn, chief financial officer, will participate in the Jefferies Healthcare Conference in June 2022.